| Molecular Medicine - CHI's 17th International Tri-Conference: Mastering Medicinal Chemistry - CHI's Seventh Annual Conference. | |
| | |
MedLine Citation:
|
PMID: 20373246 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CHI's 17th International Tri-Conference on Molecular Medicine, held in San Francisco, included topics covering the drug discovery process, with an emphasis on lead optimization. This conference report highlights selected presentations on the development of several launched and investigational drugs, including Plerixafor, Trox-1 (CombinatoRX Inc), lorcaserin (Arena Pharmaceuticals Inc), vorapaxar (Merck & Co Inc) and ulimorelin (Tranzyme Pharma Inc). |
| | |
Authors:
|
Graeme Semple |
Related Documents
:
|
12460856 - Careers of graduates of combined emergency medicine/internal medicine programs. 14530246 - Geriatrics training in general internal medicine fellowship programs: current practice,... 15209476 - Who does become an internist? 12950486 - American internal medicine in the 21st century: can an oslerian generalism survive? 11461206 - Managing workplace conflict in the united states and hong kong. 21783906 - Prioritizing veterinary pharmaceuticals for aquatic environment in korea. |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: IDrugs : the investigational drugs journal Volume: 13 ISSN: 2040-3410 ISO Abbreviation: IDrugs Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-07 Completed Date: 2010-09-14 Revised Date: 2010-12-20 |
Medline Journal Info:
|
Nlm Unique ID: 100883655 Medline TA: IDrugs Country: England |
Other Details:
|
Languages: eng Pagination: 214-8 Citation Subset: IM |
Affiliation:
|
Arena Pharmaceuticals, San Diego, CA 92127, USA. gsemple@arenapharm.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-HIV Agents / chemistry, pharmacology, therapeutic use Benzazepines / chemistry, pharmacology, therapeutic use Calcium Channel Blockers / chemistry, pharmacology, therapeutic use Chemistry, Pharmaceutical* Coronary Artery Disease / drug therapy Drug Discovery / methods, trends* Heterocyclic Compounds / chemistry, pharmacology, therapeutic use Humans Ileus / drug therapy Lactones / chemistry, pharmacology, therapeutic use Macrocyclic Compounds / chemistry, pharmacology, therapeutic use Obesity / drug therapy Pyridines / chemistry, pharmacology, therapeutic use Receptor, PAR-1 / antagonists & inhibitors Receptors, CXCR4 / antagonists & inhibitors Receptors, Ghrelin / agonists Serotonin 5-HT2 Receptor Agonists Serotonin Receptor Agonists / chemistry, pharmacology, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine; 0/Anti-HIV Agents; 0/Benzazepines; 0/CXCR4 protein, human; 0/Calcium Channel Blockers; 0/Heterocyclic Compounds; 0/Lactones; 0/Macrocyclic Compounds; 0/Pyridines; 0/Receptor, PAR-1; 0/Receptors, CXCR4; 0/Receptors, Ghrelin; 0/Serotonin 5-HT2 Receptor Agonists; 0/Serotonin Receptor Agonists; 0/TZP-101; 0/vorapaxar; 155148-31-5/JM 3100 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Molecular Medicine - CHI's 17th International Tri-Conference - Mastering Medicinal Chemistry - CHI's...
Next Document: HD Therapeutics - CHDI Fifth Annual Conference.